{"content":"<li class=\"n-box-item date-title\" data-end=\"1474689599\" data-start=\"1474603200\" data-txt=\"Sunday, December 22, 2019\">Friday, September 23, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3210650\" data-ts=\"1474671959\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEWM\" target=\"_blank\">NEWM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210650-new-media-buying-missouris-columbia-daily-tribune\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Media buying Missouri&#39;s Columbia Daily Tribune</a></h4><ul>   <li>The <i>Columbia Daily Tribune</i> of Missouri is <a href=\"http://www.bizjournals.com/stlouis/news/2016/09/23/columbia-daily-tribune-bought-by-new-york.html\" target=\"_blank\">selling to GateHouse Media</a> (<a href='https://seekingalpha.com/symbol/NEWM' title='New Media'>NEWM</a> <font color='green'>+2.6%</font>), putting a close to 115 years of local ownership.</li>    <li>Terms were undisclosed. The deal's expected to close Oct. 1.</li>    <li>Columbia will be the largest Missouri city where GateHouse, which owns a number of smaller dailies around the country, owns a paper.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210650\" data-linked=\"New Media buying Missouri&#39;s Columbia Daily Tribune\" data-tweet=\"$NEWM - New Media buying Missouri&#39;s Columbia Daily Tribune https://seekingalpha.com/news/3210650-new-media-buying-missouris-columbia-daily-tribune?source=tweet\" data-url=\"https://seekingalpha.com/news/3210650-new-media-buying-missouris-columbia-daily-tribune\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210649\" data-ts=\"1474671605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210649-asset-sales-under-way-petrobras-to-exit-braskem-stake-end-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asset sales under way, Petrobras to exit Braskem stake by end 2018</a></h4><ul>   <li>As it pursues more debt reduction, Petrobras (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='red'>-4%</font>) will <a href=\"http://www.bloomberg.com/news/articles/2016-09-23/petrobras-plans-to-sell-braskem-stake-by-end-2018-in-asset-dump\" target=\"_blank\">sell its stake in Braskem SA</a> (<a href='https://seekingalpha.com/symbol/BAK' title='Braskem S.A.'>BAK</a> <font color='green'>+1.2%</font>) before the end of 2018, its chief financial officer says.</li>    <li>There's not an exact date, but Petrobras included that stake in its plan to raise $19.5B through divestitures over the next couple of years.</li>    <li>Petrobras is the No. 2 shareholder in Braskem, holding 36% of capital and 47% of voting power. Braskem's market cap is about $5.2B.</li>    <li>Earlier, Petrobras <a href=\"https://seekingalpha.com/news/3210510-brookfield-5_2b-deal-petrobas-gas-pipeline-operation\" target=\"_blank\">agreed to sell</a> the Nova Transportadora do Sudeste natural gas distribution unit for $5.2B to a Brookfield-led consortium.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210649\" data-linked=\"Asset sales under way, Petrobras to exit Braskem stake by end 2018\" data-tweet=\"$PBR $PBR $BAK - Asset sales under way, Petrobras to exit Braskem stake by end 2018 https://seekingalpha.com/news/3210649-asset-sales-under-way-petrobras-to-exit-braskem-stake-end-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3210649-asset-sales-under-way-petrobras-to-exit-braskem-stake-end-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210648\" data-ts=\"1474670975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AOBC\" target=\"_blank\">AOBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210648-smith-wesson-slips-3_5-on-rejection-for-army-sidearm-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smith &amp; Wesson slips 3.5% on rejection for Army sidearm bid</a></h4><ul>   <li>Smith &amp; Wesson (<a href=\"https://seekingalpha.com/symbol/SWHC\" target=\"_blank\">SWHC</a> <font color=\"red\">-0.2%</font>) is <font color=\"red\">off 3.5%</font> after hours after its bid to replace the Army's standard sidearm, a Beretta M9, was rejected by the service.</li>    <li>\"We and our partner\" -- General Dynamics (<a href=\"https://seekingalpha.com/symbol/GD\" title=\"General Dynamics Corporation\">GD</a> <font color=\"red\">-0.7%</font>) -- \"in the pursuit of the U.S. Army\u2019s Modular Handgun System, or MHS, solicitation to replace the M9 standard Army sidearm have been notified by the Department of the Army that our proposal was not selected to advance to the next phase of the competition,\" the company says in an <a href=\"https://seekingalpha.com/filing/3233418\" target=\"_blank\">SEC filing</a>.</li>    <li>That program hasn't been included in Smith &amp; Wesson's guidance, it said.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210648\" data-linked=\"Smith &amp; Wesson slips 3.5% on rejection for Army sidearm bid\" data-tweet=\"$AOBC $AOBC $GD - Smith &amp; Wesson slips 3.5% on rejection for Army sidearm bid https://seekingalpha.com/news/3210648-smith-wesson-slips-3_5-on-rejection-for-army-sidearm-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3210648-smith-wesson-slips-3_5-on-rejection-for-army-sidearm-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210645\" data-ts=\"1474668002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210645-wsj-yahoo-execs-detected-russia-tied-hacking-in-2014\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: Yahoo execs detected Russia-tied hacking in 2014</a></h4><ul>    <li>The day after it disclosed a <a href=\"https://seekingalpha.com/news/3210407-yahoo-confirms-data-breach-believes-affected-500m-accounts\" target=\"_blank\">massive data breach</a> it thinks affected half a billion of its user accounts, Yahoo (<a href=\"https://seekingalpha.com/symbol/YHOO\" target=\"_blank\">YHOO</a> <font color='red'>-3.1%</font>) is facing questions over exactly when it found out about the incursion.</li>    <li>In its statement yesterday, the company said \"a copy of certain user account information was stolen from the company&rsquo;s network in late 2014 by what it believes is a state-sponsored actor.\"</li>    <li>As <a href=\"http://www.reuters.com/article/us-yahoo-cyber-questions-idUSKCN11T2JF\" target=\"_blank\">questions swirled today</a> about how it knew those things and when, a source now tells <i>The Wall Street Journal</i> that Yahoo execs <a href=\"http://www.wsj.com/articles/yahoo-executives-detected-a-hack-tied-to-russia-in-2014-1474666865\" target=\"_blank\">found hackers in their systems</a> in fall 2014 that they believed were linked to Russia, and who were seeking data on a specific 30-40 users.</li>    <li>The intrusion was discover several weeks after it happened, the source told <i>WSJ.</i> That may or may not be related to the 500M-account incident, but both incidents share the link to a \"state-sponsored actor.\"</li>    <li>The attacks were launched from computers in Russia at targets who had done business in Russia, according to the report.</li>    <li>Meanwhile, the incident has <a href=\"http://www.bloomberg.com/news/articles/2016-09-23/yahoo-s-massive-data-breach-draws-negligence-lawsuit-by-user\" target=\"_blank\">drawn a negligence suit</a> by a New York user who's seeking class action status on behalf of other users, adding another potential speed bump to Verizon's plan to acquire Yahoo.</li>    <li>Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a>) finished today <font color='green'>up 0.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210645\" data-linked=\"WSJ: Yahoo execs detected Russia-tied hacking in 2014\" data-tweet=\"$VZ $VZ $AABA - WSJ: Yahoo execs detected Russia-tied hacking in 2014 https://seekingalpha.com/news/3210645-wsj-yahoo-execs-detected-russia-tied-hacking-in-2014?source=tweet\" data-url=\"https://seekingalpha.com/news/3210645-wsj-yahoo-execs-detected-russia-tied-hacking-in-2014\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210644\" data-ts=\"1474666529\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210644-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top gainers, as of 5.25 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/ECA\" title=\"Encana Corporation\">ECA</a> <font color=\"green\">+2.6%</font>. <a href=\"https://seekingalpha.com/symbol/CNAT\" title=\"Conatus Pharmaceuticals\">CNAT</a> <font color=\"green\">+2.3%</font>. <a href=\"https://seekingalpha.com/symbol/IAG\" title=\"IAMGOLD Corporation\">IAG</a> <font color=\"green\">+2.1%</font>. <a href=\"https://seekingalpha.com/symbol/BVN\" title=\"Compañía de Minas Buenaventura S.A.A.\">BVN</a> <font color=\"green\">+1.9%</font>. <a href=\"https://seekingalpha.com/symbol/ECA\" title=\"Encana Corporation\">ECA</a> <font color=\"green\">+1.5%</font>.</li>\n<li>\n<b>Top losers, as of 5.25p.m.:</b> <a href=\"https://seekingalpha.com/symbol/ACOR\" title=\"Acorda Therapeutics, Inc.\">ACOR</a> <font color=\"red\">-8.4%</font>. SWHC <font color=\"red\">-2.5%</font>. <a href=\"https://seekingalpha.com/symbol/LXFT\" title=\"Luxoft Holding Inc\">LXFT</a> <font color=\"red\">-1.1%</font>. <a href=\"https://seekingalpha.com/symbol/GPRO\" title=\"GoPro\">GPRO</a> <font color=\"red\">-0.8%</font>. <a href=\"https://seekingalpha.com/symbol/VC\" title=\"Visteon Corporation\">VC</a> <font color=\"red\">-0.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210644\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$ECA $CNAT $IAG - After Hours Gainers / Losers https://seekingalpha.com/news/3210644-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3210644-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210643\" data-ts=\"1474666025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210643-ipo-planning-under-way-cbs-radio-setting-1_5b-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">With IPO planning under way, CBS Radio setting $1.5B debt offering</a></h4><ul>   <li>Ahead of its planned IPO, CBS Radio (<a href=\"https://seekingalpha.com/symbol/CBS\" title=\"CBS Corporation\">CBS</a> <font color=\"green\">+1.7%</font>) is <a href=\"http://www.reuters.com/article/us-cbs-corp-radio-ipo-idUSKCN11T2JR\" target=\"_blank\">setting a $1.5B debt offering</a> in order to send money to its parent, Reuters reports.</li>    <li>Some of the proceeds would be kept for general purposes, but the unit said in its registration statement that it would send up monies from a debt offering (of undisclosed size) to CBS.</li>    <li>The debt offering will be split between bonds and loans and could come before year-end, Reuters says.</li>    <li>Bank financing is being led by JPMorgan Chase, while Deutsche Bank runs the bond financing, the sources said. Meanwhile, Goldman Sachs, Wells Fargo, BofA Merrill Lynch and Credit Suisse are underwriters on the initial public offering.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210643\" data-linked=\"With IPO planning under way, CBS Radio setting $1.5B debt offering\" data-tweet=\"$CBS $VIAC - With IPO planning under way, CBS Radio setting $1.5B debt offering https://seekingalpha.com/news/3210643-ipo-planning-under-way-cbs-radio-setting-1_5b-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3210643-ipo-planning-under-way-cbs-radio-setting-1_5b-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210641\" data-ts=\"1474665147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210641-cowen-and-company-wells-fargo-unmoved-on-facebooks-ad-metric-misstep\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen and Company, Wells Fargo unmoved on Facebook&#39;s ad-metric misstep</a></h4><ul>\n<li>While Facebook (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FB\" title=\"Facebook\">FB</a>) has already issued a <a href=\"https://seekingalpha.com/news/3210570-facebook-minus-1_5-percent-executive-issues-statement-metric-miscalculation\" target=\"_blank\">statement regarding the immateriality</a> of the events, Wells Fargo's Peter Stabler and Cowen and Company's John Blackledge <a href=\"http://blogs.barrons.com/techtraderdaily/2016/09/23/facebooks-video-ad-debacle-much-ado-about-nothing-say-cowen-wells/\" target=\"_blank\">reiterate</a> similar sentiment.</li>\n<li>Stabler: \"Having reviewed multiple decks of actual campaign data and spoken with contacts on the measurement issue, we haven\u2019t encountered analysis that has dwelled on \u201caverage view time\u201d. Rather, the agency work we\u2019ve reviewed has focused on CPV (cost per view) and more importantly, CPCV (cost per completed view). CPCV allows an agency/marketer to most easily analyze video ad performance across multiple providers (and formats, e.g. pre-roll) as a completed view metric is standard. Also, recent campaign data we\u2019ve reviewed includes FB\u2019s cohort analysis (% views that achieve 25%, 50%, 75%, and 100% completion).\"</li>\n<li>Blackledge: \"In our view, this looks like a story in search of a controversy. We have every reason to expect that FB treats its metrics and definitions as sacrosanct and that this is a case of clarification versus an attempt to mislead advertisers. Perhaps most importantly, we don\u2019t think this disagreement alters the rising importance of FB in advertiser budgets.\"</li>\n<li>Both analysts maintain Outperform ratings.</li>\n<li>Facebook shares today closed <font color=\"red\">lower by 1.63%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210641\" data-linked=\"Cowen and Company, Wells Fargo unmoved on Facebook&#39;s ad-metric misstep\" data-tweet=\"$FB - Cowen and Company, Wells Fargo unmoved on Facebook&#39;s ad-metric misstep https://seekingalpha.com/news/3210641-cowen-and-company-wells-fargo-unmoved-on-facebooks-ad-metric-misstep?source=tweet\" data-url=\"https://seekingalpha.com/news/3210641-cowen-and-company-wells-fargo-unmoved-on-facebooks-ad-metric-misstep\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210623\" data-ts=\"1474658777\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210623-twitter-moonshot-sends-social-media-etf-to-record-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter moonshot sends Social Media ETF to record high</a></h4><ul><li>Twitter is&nbsp;<font color='green'>ahead 21.5%</font>&nbsp;today to its highest level since January <a href=\"https://seekingalpha.com/news/3210596-citi-considers-twitter-salesforce-deal-unlikely\" target=\"_blank\">on chatter of</a> takeover interest by the likes of Salesforce.com and Google.</li><li><a href=\"http://blogs.barrons.com/focusonfunds/2016/09/23/twitter-deal-rumors-power-social-media-etf-to-record-high/?mod=BOL_hp_blog_fof\" target=\"_blank\">That's sending the</a> Global X Social Media Index (NASDAQ:<a href='https://seekingalpha.com/symbol/SOCL' title='Global X Social Media Index ETF'>SOCL</a>) - which has a beefy 8.9% position in Twitter -&nbsp;<font color='green'>higher by 1.3%</font>&nbsp;today, and now up by a&nbsp;<font color='green'>whopping 62%&nbsp;</font>from the February bottom.</li><li>Related ETFs: <a href='https://seekingalpha.com/symbol/FDN' title='First Trust DJ Internet Index ETF'>FDN</a>, <a href='https://seekingalpha.com/symbol/PNQI' title='PowerShares NASDAQ Internet Portfolio ETF'>PNQI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3210623\" data-linked=\"Twitter moonshot sends Social Media ETF to record high\" data-tweet=\"$SOCL $FDN $PNQI - Twitter moonshot sends Social Media ETF to record high https://seekingalpha.com/news/3210623-twitter-moonshot-sends-social-media-etf-to-record-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3210623-twitter-moonshot-sends-social-media-etf-to-record-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210618\" data-ts=\"1474657881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210618-yelp-caught-in-m-chatter-up-2_6-ends-dual-class-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp caught in M&amp;A chatter, up 2.6%; ends dual-class shares</a></h4><ul>   <li>Yelp (NYSE:<a href=\"https://seekingalpha.com/symbol/YELP\" title=\"Yelp\">YELP</a>) today announced the conversion of its Class A and B shares into a single class of stock, though its moves today (now <font color=\"green\">up 2.6%</font>) are being attributed to Twitter's <a href=\"https://seekingalpha.com/news/3210545-twitter-plus-17-percent-pre-market-m-speculation-recirculating\" target=\"_blank\">M&amp;A rumor-fueled</a> <font color=\"green\">20% jump</font>.</li>    <li>Yelp has spurned big suitors so far though it's rumored to have drawn interest (at various times) from <a href=\"https://seekingalpha.com/news/3000036\" target=\"_blank\">Priceline</a>, <a href=\"https://seekingalpha.com/news/2508086\" target=\"_blank\">Yahoo, Google</a>, and Facebook, as well as TripAdvisor or Expedia.</li>    <li>The company had reportedly hired banks in spring 2015 to find a buyer.</li>    <li>The share-class conversion took effect at 5 p.m. ET yesterday, and had no economic effect but elmiinated the different voting powers. The conversion was automatic as outstanding class B stock represented laess than 10% of outstanding shares.</li>    <li>All shares are now entitled to one vote per share.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210618\" data-linked=\"Yelp caught in M&amp;A chatter, up 2.6%; ends dual-class shares\" data-tweet=\"$YELP - Yelp caught in M&amp;A chatter, up 2.6%; ends dual-class shares https://seekingalpha.com/news/3210618-yelp-caught-in-m-chatter-up-2_6-ends-dual-class-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3210618-yelp-caught-in-m-chatter-up-2_6-ends-dual-class-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210612\" data-ts=\"1474655041\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210612-appleminus-1_8-on-rumored-gfk-channel-checks-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple -1.8% on rumored GfK channel checks [updated]</a></h4><ul>\n<li>Apple (<a href=\"https://seekingalpha.com/symbol/AAPL\" title=\"Apple Inc.\">AAPL</a> <font color=\"red\">-1.8%</font>) shares were stable throughout the day, though took a sharp downward turn within the last hour on a <a href=\"http://twitter.com/juleshyman/status/779381283378098176\" target=\"_blank\">supposed</a> iPhone 7-related report out of market research firm <a href=\"http://www.gfk.com\" target=\"_blank\">GfK</a>.</li>\n<li>\n<strong>Update (3:35PM ET)</strong>: GfK <a href=\"http://www.cnbc.com/2016/09/23/apple-shares-dip-2-amid-iphone-sales-concerns.html?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&amp;par=yahoo&amp;doc=103965087&amp;yptr=yahoo\" target=\"_blank\">has confirmed</a> existence of a report, though won't publicly disclose any of its data. From 1:30PM ET to 2:00PM ET, Apple shares <font color=\"red\">dropped 2.3%</font>. While third-party research can't offer concrete indicators of a company's performance, such reports can and do impact share price, and in this case, the report out of GfK appears clearly attributable to the sell-off.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210612\" data-linked=\"Apple -1.8% on rumored GfK channel checks [updated]\" data-tweet=\"$AAPL - Apple -1.8% on rumored GfK channel checks [updated] https://seekingalpha.com/news/3210612-appleminus-1_8-on-rumored-gfk-channel-checks-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3210612-appleminus-1_8-on-rumored-gfk-channel-checks-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>299&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210611\" data-ts=\"1474653962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210611-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li><b>Gainers:</b> TCK <font color='green'>+7%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GURE' title='GULF RESOURCES INC'>GURE</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/PQ' title='PetroQuest Energy Inc.'>PQ</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CWEI' title='Clayton Williams Energy, Inc.'>CWEI</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/TDW' title='Tidewater, Inc.'>TDW</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/WPX' title='WPX Energy, Inc.'>WPX</a> <font color='red'>-8%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3210611\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$TECK $GURE $PQ - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3210611-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3210611-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210608\" data-ts=\"1474653064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACIU\" target=\"_blank\">ACIU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210608-ac-immune-debuts-strongly-shares-up-45\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AC Immune debuts strongly; shares up 45%</a></h4><ul>\n<li>IPO AC Immune (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ACIU\" title=\"AC Immune SA\">ACIU</a>) comes out the blocks with some muscle. Shares are up <font color=\"green\">45%</font> on turnover of 3.3M. Its lead product candidate is crenezumab for the treatment of Alzheimer's.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3209393-ac-immune-deck-ipo\" target=\"_blank\">AC Immune on deck for IPO</a> (Sept. 16)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210608\" data-linked=\"AC Immune debuts strongly; shares up 45%\" data-tweet=\"$ACIU - AC Immune debuts strongly; shares up 45% https://seekingalpha.com/news/3210608-ac-immune-debuts-strongly-shares-up-45?source=tweet\" data-url=\"https://seekingalpha.com/news/3210608-ac-immune-debuts-strongly-shares-up-45\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210607\" data-ts=\"1474652735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AHC\" target=\"_blank\">AHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210607-dallas-newspaper-owner-beloplus-13_8-on-report-of-gannett-buyout-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dallas newspaper owner Belo +13.8% on report of Gannett buyout interest</a></h4><ul>   <li><i>Dallas Morning News</i> owner A.H. Belo (NYSE:<a href='https://seekingalpha.com/symbol/AHC' title='A.H. Belo Corporation'>AHC</a>) is <font color='green'>up 13.8%</font> now after a <a href=\"http://nypost.com/2016/09/22/gannett-mulls-acquiring-dallas-morning-news-owner-a-h-belo/\" target=\"_blank\">report</a> from the <i>New York Post</i> that acquisitive Gannett (<a href='https://seekingalpha.com/symbol/GCI' title='Gannett Co., Inc.'>GCI</a> <font color='green'>+1%)</font> is considering a buyout offer.</li>    <li>Sources told the <i>Post</i> that such a deal wouldn't affect overtures by Gannett to buy Tronc (TRNC), the former Tribune Publishing. Belo has about a $150M market value and Gannett could still pay $1B for Tronc.</li>    <li>Gannett has scheduled a special board meeting for next week, a source told the <i>Post.</i></li>    <li>Any sale would likely need to convince not only Belo Chairman/CEO James Moroney, but bigger stockholder Robert Decherd (Moroney's cousin), as well as Decherd's sister Dealey Herndon.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210607\" data-linked=\"Dallas newspaper owner Belo +13.8% on report of Gannett buyout interest\" data-tweet=\"$AHC $AHC $GCI - Dallas newspaper owner Belo +13.8% on report of Gannett buyout interest https://seekingalpha.com/news/3210607-dallas-newspaper-owner-beloplus-13_8-on-report-of-gannett-buyout-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3210607-dallas-newspaper-owner-beloplus-13_8-on-report-of-gannett-buyout-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210596\" data-ts=\"1474650194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210596-citi-considers-twitter-salesforce-deal-unlikely\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi considers Twitter, Salesforce deal unlikely</a></h4><ul>\n<li>With Twitter (<a href=\"https://seekingalpha.com/symbol/TWTR\" title=\"Twitter, Inc.\">TWTR</a> <font color=\"green\">+18.2%</font>) and Salesforce (<a href=\"https://seekingalpha.com/symbol/CRM\" title=\"Salesforce.com, Inc.\">CRM</a> <font color=\"red\">-5.3%</font>) trading in opposite directions on <a href=\"https://seekingalpha.com/news/3210566-salesforces-vala-afshar-tweets-ambiguous-message-amid-twitter-takeover-speculation\" target=\"_blank\">today's buzz</a>, Citi's Walter Pritchard <a href=\"http://blogs.barrons.com/techtraderdaily/2016/09/23/salesforce-for-twitter-not-likely-says-citi/\" target=\"_blank\">states his position</a> that the likelihood of a deal between the two is low and doesn't like the opportunity for Salesforce should one materialize.</li>\n<li>Pritchard: \"While Twitter is involved in the customer service process, we don\u2019t believe it is necessary for salesforce to own Twitter to be able to use it as a medium for customer service. Also, we don\u2019t believe that if someone else bought Twitter, salesforce would be prevented from using Twitter as they do today. Our response, if CRM were to buy TWTR, would be negative. Twitter is profitable and while back of the envelope the deal might not be dilutive, we believe it would fuel concerns that CRM is de-focusing on for \u201ccustomer\u201d area in a quest to stretch for growth.\"</li>\n<li>Maintains a Buy rating on Salesforce amid the speculation.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210596\" data-linked=\"Citi considers Twitter, Salesforce deal unlikely\" data-tweet=\"$TWTR $TWTR $CRM - Citi considers Twitter, Salesforce deal unlikely https://seekingalpha.com/news/3210596-citi-considers-twitter-salesforce-deal-unlikely?source=tweet\" data-url=\"https://seekingalpha.com/news/3210596-citi-considers-twitter-salesforce-deal-unlikely\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210599\" data-ts=\"1474650152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210599-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SC' title='Santander Consumer USA Holdings Inc'>SC</a> <font color='green'>+11%</font>. USBI <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/KCG' title='KCG Holdings, Inc.'>KCG</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HOMB' title='Home BancShares, Inc.'>HOMB</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3210599\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$SC $FUSB $KCG - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3210599-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3210599-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210594\" data-ts=\"1474649119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210594-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/IMPV\" title=\"Imperva, Inc.\">IMPV</a> <font color=\"green\">+22%</font>. <a href=\"https://seekingalpha.com/symbol/BLRX\" title=\"BioLineRx Ltd.\">BLRX</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/MRNS\" title=\"Marinus Pharmaceuticals\">MRNS</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/TWTR\" title=\"Twitter, Inc.\">TWTR</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/ENDP\" title=\"Endo International plc\">ENDP</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/CPRX\" title=\"Catalyst Pharmaceuticals, Inc.\">CPRX</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/SCYX\" title=\"SCYNEXIS, Inc.\">SCYX</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/INVE\" title=\"Identiv, Inc.\">INVE</a> <font color=\"green\">+11%</font>. MIFI <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/CIDM\" title=\"Cinedigm Corp.\">CIDM</a> <font color=\"green\">+11%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/ENPH\" title=\"Enphase Energy Inc.\">ENPH</a> <font color=\"red\">-26%</font>. <a href=\"https://seekingalpha.com/symbol/APPS\" title=\"Digital Turbine, Inc.\">APPS</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/RAVE\" title=\"RAVE Restaurant Group, Inc.\">RAVE</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/CATB\" title=\"Catabasis Pharmaceuticals\">CATB</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/BCEI\" title=\"Bonanza Creek Energy\">BCEI</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/HMHC\" title=\"HMH Holdings (Delaware), Inc.\">HMHC</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/PQ\" title=\"PetroQuest Energy Inc.\">PQ</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/CRBP\" title=\"Corbus Pharmaceuticals Holdings, Inc.\">CRBP</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/RETA\" title=\"Reata Pharmaceuticals\">RETA</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/OSK\" title=\"Oshkosh Corporation\">OSK</a> <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210594\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$IMPV $BLRX $MRNS - Midday Gainers / Losers https://seekingalpha.com/news/3210594-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3210594-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210590\" data-ts=\"1474647920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210590-energy-shares-lead-market-lower-oil-dips-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy shares lead market lower as oil dips 3%</a></h4><ul><li>Oil is still set for a weekly gain, but is<font color='red'> lower by 3%</font>&nbsp;on today's session to $44.96 per barrel. Black gold began the week at about $44. <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>&nbsp;<font color='red'>-2.85%</font></li><li>Alongside oil's drop, the energy sector (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color='red'>-1.3%</font>) is far outpacing the&nbsp;<font color='red'>0.3% decline</font>&nbsp;for the broad averages.</li></ul><div class=\"tiny-share-widget\" data-id=\"3210590\" data-linked=\"Energy shares lead market lower as oil dips 3%\" data-tweet=\"$USO $XLE - Energy shares lead market lower as oil dips 3% https://seekingalpha.com/news/3210590-energy-shares-lead-market-lower-oil-dips-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3210590-energy-shares-lead-market-lower-oil-dips-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210588\" data-ts=\"1474647587\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IVR\" target=\"_blank\">IVR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210588-invesco-mortgageminus-3-ceo-sets-retirement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Invesco Mortgage -3% as CEO sets retirement</a></h4><ul>\n<li>Invesco Mortgage (<a href=\"https://seekingalpha.com/symbol/IVR\" title=\"Invesco Mortgage Capital Inc.\">IVR</a> <font color=\"red\">-3.2%</font>) CEO and President Richard King <a href=\"https://seekingalpha.com/filing/3231732\" target=\"_blank\">will retire on March 1, 2017</a>. He's to be replaced in the CEO role by current CIO John Anzalone, and current COO Rob Kuster will assume the role of president.</li>\n<li>All three have been part of IVR's investment committee the company was founded in 2008.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210588\" data-linked=\"Invesco Mortgage -3% as CEO sets retirement\" data-tweet=\"$IVR - Invesco Mortgage -3% as CEO sets retirement https://seekingalpha.com/news/3210588-invesco-mortgageminus-3-ceo-sets-retirement?source=tweet\" data-url=\"https://seekingalpha.com/news/3210588-invesco-mortgageminus-3-ceo-sets-retirement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210584\" data-ts=\"1474646456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210584-consumer-goods-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/HY\" title=\"Hyster-Yale Materials Handling, Inc.\">HY</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/FBR\" title=\"Fibria Celulose S.A.\">FBR</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/GPRO\" title=\"GoPro\">GPRO</a> <font color=\"green\">+6%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/OSK\" title=\"Oshkosh Corporation\">OSK</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/SYUT\" title=\"Synutra International, Inc.\">SYUT</a> <font color=\"red\">-5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210584\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$HY $FBR $GPRO - Consumer Goods - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3210584-consumer-goods-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3210584-consumer-goods-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210580\" data-ts=\"1474644703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHU\" target=\"_blank\">CHU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210580-goldman-swaps-china-mobile-for-china-unicom-on-bigger-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman swaps China Mobile for China Unicom on bigger upside</a></h4><ul>   <li>Goldman Sachs has changed its mind on China's state-owned telecoms, and made a switch.</li>    <li>In favor now is China Unicom (<a href=\"https://seekingalpha.com/symbol/CHU\" title=\"China Unicom (Hong Kong) Limited\">CHU</a> <font color=\"green\">+0.1%</font>), added to the firm's <a href=\"http://blogs.barrons.com/asiastocks/2016/09/23/why-goldman-swaps-china-mobile-for-china-unicom/\" target=\"_blank\">Conviction Buy list</a> from a previous Neutral stance, while China Mobile (<a href=\"https://seekingalpha.com/symbol/CHL\" title=\"China Mobile Limited\">CHL</a> <font color=\"red\">-1%</font>) gets a downgrade to Neutral.</li>    <li>China Mobile <font color=\"red\">declined 0.9%</font> in Hong Kong today, while China Unicom <font color=\"green\">picked up 4.3%</font>.</li>    <li>China Mobile, the country's 4G market leader, is having the better year -- <font color=\"green\">up 10.2%</font> YTD in U.S. trading, vs. China Unicom's <font color=\"green\">gain of 1.4%</font> -- so analyst Donald Lu sees Unicom as \"glass half full\" and China Mobile as \"half empty.\"</li>    <li>Rapid data growth is tailing off at China Mobile (170% to 104% from Q1 to Q2) and is heading to 72% in 2017, Lu says, while Unicom has 4G penetration of just 30% (vs. China Mobile's 54% and China Telecom's (<a href=\"https://seekingalpha.com/symbol/CHA\" title=\"China Telecom Corporation Limited\">CHA</a> <font color=\"red\">-0.1%</font>) 46%).</li>    <li>China Unicom also has the biggest exposure to China Tower, which Goldman estimates is worth $47B and is headed for an IPO next year. That firm owns 98% of China's telecom towers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210580\" data-linked=\"Goldman swaps China Mobile for China Unicom on bigger upside\" data-tweet=\"$CHU $CHU $CHL - Goldman swaps China Mobile for China Unicom on bigger upside https://seekingalpha.com/news/3210580-goldman-swaps-china-mobile-for-china-unicom-on-bigger-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3210580-goldman-swaps-china-mobile-for-china-unicom-on-bigger-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210570\" data-ts=\"1474642879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210570-facebookminus-1_5-executive-issues-statement-on-metric-miscalculation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook -1.5%; executive issues statement on metric miscalculation</a></h4><ul>\n<li>Following <a href=\"https://seekingalpha.com/news/3210489-facebook-inflated-video-metrics-two-years\" target=\"_blank\">news</a> Facebook (<a href=\"https://seekingalpha.com/symbol/FB\" title=\"Facebook\">FB</a> <font color=\"red\">-1.5%</font>) had been inaccurately computing average viewing time figures, company executive <a href=\"https://www.facebook.com/fischer/posts/10157497355045187\" target=\"_blank\">David Fischer asserts</a> the minimal impact it's had or will have on ad partners.</li>\n<li>Excerpt: \"As soon as we discovered the discrepancy, we fixed it. We informed our partners and made sure to put a notice in the product itself so that anyone who went into their dashboard could understand our error. We have also reviewed our other video metrics on the dashboard and have found that this has no impact on video numbers we have shared in the past, such as time spent watching video or the number of video views. We want our clients to know that this miscalculation has not and will not going forward have an impact on billing or how media mix models value their Facebook video investments.\"</li>\n<li>With the company ramping ad initiatives of late (<a href=\"https://seekingalpha.com/news/3210351-instagram-records-500k-advertisers\" target=\"_blank\">500K Instagram advertisers</a>, <a href=\"https://seekingalpha.com/news/3210127-facebook-expands-ad-measurement-partnerships\" target=\"_blank\">new ad-measurement partnerships</a>, <a href=\"http://www.facebook.com/business/news/dynamic-ads-for-retail-launch\" target=\"_blank\">new brick-and-mortar ad products</a>), the news may be of short-term concern, though appears relatively minor long-term as Facebook addresses the issue and in-all-likelihood increases focus to ensure metric computations are engineered accurately going forward.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210570\" data-linked=\"Facebook -1.5%; executive issues statement on metric miscalculation\" data-tweet=\"$FB - Facebook -1.5%; executive issues statement on metric miscalculation https://seekingalpha.com/news/3210570-facebookminus-1_5-executive-issues-statement-on-metric-miscalculation?source=tweet\" data-url=\"https://seekingalpha.com/news/3210570-facebookminus-1_5-executive-issues-statement-on-metric-miscalculation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>83&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210560\" data-ts=\"1474642871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210560-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/MRNS\" title=\"Marinus Pharmaceuticals\">MRNS</a> <font color=\"green\">+24%</font>. <a href=\"https://seekingalpha.com/symbol/BLRX\" title=\"BioLineRx Ltd.\">BLRX</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/CPRX\" title=\"Catalyst Pharmaceuticals, Inc.\">CPRX</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/ENDP\" title=\"Endo International plc\">ENDP</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/NVAX\" title=\"Novavax, Inc.\">NVAX</a> <font color=\"green\">+9%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/CATB\" title=\"Catabasis Pharmaceuticals\">CATB</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/IPCI\" title=\"IntelliPharmaCeutics International Inc\">IPCI</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/CRBP\" title=\"Corbus Pharmaceuticals Holdings, Inc.\">CRBP</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/ADMP\" title=\"Adamis Pharmaceuticals Corp.\">ADMP</a> <font color=\"red\">-5%</font>. <a href=\"https://seekingalpha.com/symbol/AVXL\" title=\"Anavex Life Sciences Corp.\">AVXL</a> <font color=\"red\">-5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210560\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$MRNS $BLRX $CPRX - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3210560-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3210560-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210571\" data-ts=\"1474642761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRNS\" target=\"_blank\">MRNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210571-increase-in-enrollment-in-marinus-pharmas-mid-stage-study-appears-to-excite-investors-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Increase in enrollment in Marinus Pharma&#39;s mid-stage study appears to excite investors, shares up 27%</a></h4><ul>\n<li>Investors appear a bit giddy over the increase in target enrollment in Marinus Pharmaceuticals' (<a href=\"https://seekingalpha.com/symbol/MRNS\" title=\"Marinus Pharmaceuticals\">MRNS</a> <font color=\"green\">+27.3%</font>) <a href=\"https://clinicaltrials.gov/ct2/show/NCT02358538?term=marinus&amp;rank=3&amp;submit_fld_opt=\" target=\"_blank\">Phase 2 study</a> evaluating lead product candidate ganaxolone in female children with rare genetic epilepsies, including those with a mutation called PCDH19, characterized by early onset seizures.</li>\n<li>Target enrollment is now 50, up from 20 in January. Frequently, though, the sponsor increases the number of study participants when the current number is insufficient to demonstrate efficacy.</li>\n<li>The primary endpoint of the open-label, proof-of-concept study is the percent change in seizure frequency from baseline (each 28 days) over 26 weeks based on a daily seizure diary.</li>\n<li>In June, shares plummeted on the news that ganaxolone flunked a late-stage study in adults with drug-resistant focal onset seizures. It also failed a mid-stage study in children with Fragile X syndrome.</li>\n<li>\n<a href=\"http://www.marinuspharma.com/#!ganaxolone/cxnj\" target=\"_blank\">Ganaxolone </a>is a small molecule inhibitor of the neurotransmitter GABA, which helps control epileptic seizures.</li>\n<li>Read now <a href=\"https://seekingalpha.com/article/3985275-next-investors-marinus-pharmaceuticals-failed-trial-ganaxolone-fragile-x-syndrome\" target=\"_blank\">What Is Next For Investors Of Marinus Pharmaceuticals After \"Failed\" Trial of Ganaxolone In Fragile X Syndrome</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210571\" data-linked=\"Increase in enrollment in Marinus Pharma&#39;s mid-stage study appears to excite investors, shares up 27%\" data-tweet=\"$MRNS - Increase in enrollment in Marinus Pharma&#39;s mid-stage study appears to excite investors, shares up 27% https://seekingalpha.com/news/3210571-increase-in-enrollment-in-marinus-pharmas-mid-stage-study-appears-to-excite-investors-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3210571-increase-in-enrollment-in-marinus-pharmas-mid-stage-study-appears-to-excite-investors-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210572\" data-ts=\"1474642548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FBC\" target=\"_blank\">FBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210572-flagstar-rally-pauses-sandler-oneill-rings-register\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flagstar rally pauses as Sandler O&#39;Neill rings the register</a></h4><ul>\n<li>The bank's <font color=\"green\">higher by 19%</font> YTD, and by <font color=\"green\">more than 50%</font> from a late-January low amid positive results from restructuring efforts and the okay from the Feds to redeem its TARP preferred stock.</li>\n<li>Sandler O'Neill downgrades to Hold from Buy.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/FBC\" title=\"Flagstar Bancorp, Inc.\">FBC</a> <font color=\"red\">-1.8%</font> to $27.52</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210572\" data-linked=\"Flagstar rally pauses as Sandler O&#39;Neill rings the register\" data-tweet=\"$FBC - Flagstar rally pauses as Sandler O&#39;Neill rings the register https://seekingalpha.com/news/3210572-flagstar-rally-pauses-sandler-oneill-rings-register?source=tweet\" data-url=\"https://seekingalpha.com/news/3210572-flagstar-rally-pauses-sandler-oneill-rings-register\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210569\" data-ts=\"1474641867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPTA\" target=\"_blank\">CPTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210569-capitala-finance-plunges-after-dividend-cut-two-downgrades-hit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Capitala Finance plunges after dividend cut; two downgrades hit</a></h4><ul>\n<li>The company <a href=\"https://seekingalpha.com/news/3210455-capitala-finance-declares-0_13-dividend\" target=\"_blank\">overnight slashed</a> its payout this quarter to $0.39 from $0.47.</li>\n<li>JMP downgrades to Market Perform from Outperform, and Wunderlich to Hold from Buy.</li>\n<li>Maintaining his Market Perform rating and $15 price target, <a href=\"http://www.streetinsider.com/Analyst+Comments/FBR+Capital+Reiterates+Market+Perform+as+Capitala+Finance+%28CPTA%29+Announces+Dividend+Reduction+/12065297.html\" target=\"_blank\">FBR's Chris Nolan says</a> the cut is consistent with what he expected. The lower dividend in part reflects portfolio exits, particularly from energy, and may also mean a slowing pace of new deal origination in Q3. Going forward, the smaller payout likely eliminates the need for the management fee waiver, but said waiver remains in place to ensure adequate coverage. \"In our view, this credibly reflects on management.\"</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/CPTA\" title=\"Capitala Finance Corp\">CPTA</a> <font color=\"red\">-10.1%</font> to $13.10.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210569\" data-linked=\"Capitala Finance plunges after dividend cut; two downgrades hit\" data-tweet=\"$CPTA - Capitala Finance plunges after dividend cut; two downgrades hit https://seekingalpha.com/news/3210569-capitala-finance-plunges-after-dividend-cut-two-downgrades-hit?source=tweet\" data-url=\"https://seekingalpha.com/news/3210569-capitala-finance-plunges-after-dividend-cut-two-downgrades-hit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210568\" data-ts=\"1474641577\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VOD\" target=\"_blank\">VOD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210568-vodafone-building-multimillion-dollar-chest-for-war-jio\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vodafone building multimillion-dollar chest for war with Jio</a></h4><ul>   <li>Vodafone (<a href=\"https://seekingalpha.com/symbol/VOD\" title=\"Vodafone Group Plc\">VOD</a> <font color=\"red\">-1.7%</font>) is <a href=\"http://telecoms.com/475792/vodafone-boosts-indian-war-chest-for-jio-fight/\" target=\"_blank\">pouring billions into its Indian operations</a> as it prepares for a bruising competition with Reliance Jio -- the upstart mobile operator arm of India's richest man that has shaken the market with an aggressive price entry.</li>    <li>Jio has announced commercial wireless service coming at the end of the year as a 100% 4G player in an unusually competitive market: It's the 12th competitor in India, vs. markets that generally have three or four. It also has the country's largest hoard of spectrum, along with a complete vertically integrated setup.</li>    <li>Vodafone -- No. 2 in the market, behind Bharti Airtel -- has moved around $7.2B from Newbury to its India operations, preparing for a fight on multiple fronts including a pricey spectrum auction.</li>    <li>Vodafone India is also heavily indebted. That infusion, \"which we believe is the largest ever in India, will enable Vodafone India to continue its investments in spectrum and expansion of networks across various technology layers delivering the best of experience to our hundreds of million customers,\u201d says Vodafone India CEO Sunil Sood.</li>    <li>Two other major operators (Reliance and Aircel) have elected to pool resources for the competition ahead.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210568\" data-linked=\"Vodafone building multimillion-dollar chest for war with Jio\" data-tweet=\"$VOD - Vodafone building multimillion-dollar chest for war with Jio https://seekingalpha.com/news/3210568-vodafone-building-multimillion-dollar-chest-for-war-jio?source=tweet\" data-url=\"https://seekingalpha.com/news/3210568-vodafone-building-multimillion-dollar-chest-for-war-jio\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210567\" data-ts=\"1474640779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APPS\" target=\"_blank\">APPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210567-digital-turbineminus-13-prices-16m-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digital Turbine -13% as it prices $16M debt offering</a></h4><ul>   <li>Digital Turbine (NASDAQ:<a href=\"https://seekingalpha.com/symbol/APPS\" title=\"Digital Turbine, Inc.\">APPS</a>) is <font color=\"red\">off 13.2%</font> after pricing a debt offering of $16M.</li>    <li>The company is selling that amount in 8.75% convertible senior notes due 2020, in private placement expected to close Wednesday.</li>    <li>The initial conversion rate for the notes is 733.14 shares per $1,000 principal, equivalent to a conversion price of $1.364/share, a 10% conversion premium from yesterday. Purchasers also get warrants to buy 256.60 shares of common stock for each $1,000 in notes bought. Those are exercisable at an initial price of $1.364/share.</li>    <li>Proceeds from the unsecured-note sale will be used to repay about $11M on secured indebtedness and for general purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3210567\" data-linked=\"Digital Turbine -13% as it prices $16M debt offering\" data-tweet=\"$APPS - Digital Turbine -13% as it prices $16M debt offering https://seekingalpha.com/news/3210567-digital-turbineminus-13-prices-16m-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3210567-digital-turbineminus-13-prices-16m-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210566\" data-ts=\"1474640294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210566-salesforces-vala-afshar-tweets-ambiguous-message-amid-twitter-takeover-speculation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Salesforce&#39;s Vala Afshar tweets ambiguous message amid Twitter takeover speculation</a></h4><ul><li><a href=\"https://twitter.com/ValaAfshar/status/779311514134118400\" target=\"_blank\">On Twitter</a>.</li><li>Resurfaced rumors of a buyout were sparked earlier by <a href=\"https://twitter.com/CNBCnow/status/779311639141101568\" target=\"_blank\">CNBC's David Faber</a>.</li><li>While a tweet doesn't offer anything in the way of clarity on an actual deal, the move upward in Twitter (<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a> <font color='green'>+20.2%</font>) and downward in Salesforce (<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a> <font color='red'>-3.7%</font>) offers perspective on sentiment should one occur.</li></ul><div class=\"tiny-share-widget\" data-id=\"3210566\" data-linked=\"Salesforce&#39;s Vala Afshar tweets ambiguous message amid Twitter takeover speculation\" data-tweet=\"$TWTR $TWTR $CRM - Salesforce&#39;s Vala Afshar tweets ambiguous message amid Twitter takeover speculation https://seekingalpha.com/news/3210566-salesforces-vala-afshar-tweets-ambiguous-message-amid-twitter-takeover-speculation?source=tweet\" data-url=\"https://seekingalpha.com/news/3210566-salesforces-vala-afshar-tweets-ambiguous-message-amid-twitter-takeover-speculation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210561\" data-ts=\"1474639088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PKG\" target=\"_blank\">PKG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210561-packaging-corp-and-kapstone-upgraded-deustche\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Packaging Corp. and KapStone upgraded at Deustche</a></h4><ul><li>One day after Goldman Sachs<a href=\"https://seekingalpha.com/news/3210322-goldman-sachs-turns-negative-packaging-corporation-america\" target=\"_blank\"> initiated coverage</a> on Packaging Corp. of America (NYSE:<a href='https://seekingalpha.com/symbol/PKG' title='Packaging Corporation Of America'>PKG</a>) with a Sell, and two days after KapStone (NYSE:<a href='https://seekingalpha.com/symbol/KS' title='KapStone Paper and Packaging Corporation'>KS</a>) replaced its CEO, the <a href=\"http://www.streetinsider.com/Upgrades/Deutsche+Bank+Upgrades+KapStone+%28KS%29+and+Packaging+Corp+%28PKG%29+to+Buy/12065033.html\" target=\"_blank\">two are upgraded</a> to Buy at Deustche Bank.</li><li>PKG is&nbsp;<font color='green'>higher by 1.5%</font>&nbsp;and KS&nbsp;<font color='green'>by 3%</font>&nbsp;in today's session. The journey for the two this year, however, has diverged, with PKG&nbsp;<font color='green'>up 29.7%</font>&nbsp;and KS&nbsp;<font color='red'>down 12.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3210561\" data-linked=\"Packaging Corp. and KapStone upgraded at Deustche\" data-tweet=\"$PKG $PKG $KS - Packaging Corp. and KapStone upgraded at Deustche https://seekingalpha.com/news/3210561-packaging-corp-and-kapstone-upgraded-deustche?source=tweet\" data-url=\"https://seekingalpha.com/news/3210561-packaging-corp-and-kapstone-upgraded-deustche\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210558\" data-ts=\"1474638694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRNS\" target=\"_blank\">MRNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210558-marinus-soars-on-expansion-of-epilepsy-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marinus soars on expansion of epilepsy trial</a></h4><ul><li>Marinus Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a>)&nbsp;jumps more than <font color='green'>20%</font> to $2.19.</li><li>The company <a href=\"https://clinicaltrials.gov/ct2/show/NCT02358538?term=marinus&amp;rank=3&amp;submit_fld_opt=\" target=\"_blank\">updated its PCDH19 trial</a>; now shows expansion to 50 patients.</li></ul><div class=\"tiny-share-widget\" data-id=\"3210558\" data-linked=\"Marinus soars on expansion of epilepsy trial\" data-tweet=\"$MRNS - Marinus soars on expansion of epilepsy trial https://seekingalpha.com/news/3210558-marinus-soars-on-expansion-of-epilepsy-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/3210558-marinus-soars-on-expansion-of-epilepsy-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210557\" data-ts=\"1474638669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COG\" target=\"_blank\">COG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210557-two-notch-upgrade-for-cabot-oil-gas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Two-notch upgrade for Cabot Oil &amp; Gas</a></h4><ul><li>Hot-handed Cabot Oil &amp; Gas (<a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a> <font color='green'>+1.4%</font>) gets another boost as Raymond James <a href=\"http://www.streetinsider.com/Hot+Upgrades/Raymond+James+Upgrades+Cabot+Oil+%26+Gas+%28COG%29+to+Strong+Buy/12065086.html\" target=\"_blank\">upgrades to Strong Buy</a> from Market Perform.</li><li>With today's advance, the stock is&nbsp;<font color='green'>higher by 46.4%</font>&nbsp;YTD.</li></ul><div class=\"tiny-share-widget\" data-id=\"3210557\" data-linked=\"Two-notch upgrade for Cabot Oil &amp; Gas\" data-tweet=\"$COG - Two-notch upgrade for Cabot Oil &amp; Gas https://seekingalpha.com/news/3210557-two-notch-upgrade-for-cabot-oil-gas?source=tweet\" data-url=\"https://seekingalpha.com/news/3210557-two-notch-upgrade-for-cabot-oil-gas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210556\" data-ts=\"1474638510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALGT\" target=\"_blank\">ALGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210556-allegiant-travel-higher-buckingham-buys-dip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allegiant Travel higher as Buckingham buys the dip</a></h4><ul>\n<li>Buckingham Research <a href=\"http://www.streetinsider.com/Upgrades/Buckingham+Research+Upgrades+Allegiant+Travel+Company+%28ALGT%29+to+Buy/12065281.html\" target=\"_blank\">upgrades</a> Allegiant Travel (<a href=\"https://seekingalpha.com/symbol/ALGT\" title=\"Allegiant Travel Company\">ALGT</a> <font color=\"green\">+1.1%</font>) to Buy from Neutral. The price target of $168 suggests more than <font color=\"green\">30% upside</font>.</li>\n<li>Allegiant is<font color=\"red\"> lower by 23%</font> YTD.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210556\" data-linked=\"Allegiant Travel higher as Buckingham buys the dip\" data-tweet=\"$ALGT - Allegiant Travel higher as Buckingham buys the dip https://seekingalpha.com/news/3210556-allegiant-travel-higher-buckingham-buys-dip?source=tweet\" data-url=\"https://seekingalpha.com/news/3210556-allegiant-travel-higher-buckingham-buys-dip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210549\" data-ts=\"1474636852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FXC\" target=\"_blank\">FXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210549-loonie-lower-on-soft-economic-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Loonie lower on soft economic data</a></h4><ul>\n<li>\n<a href=\"http://www.theglobeandmail.com/report-on-business/economy/canadas-inflation-rate-sinks-to-10-month-low/article32019571/\" target=\"_blank\">Canada's year-over-year </a>inflation rate slipped to 1.1% in August from 1.3% a month earlier. Core inflation fell to a more than two year low of 1.8% from 2.1%. Economists had expected inflation at 1.4% and core inflation at 2%.</li>\n<li>July retail sales fell 0.1% from June vs. expectations for a 0.1% increase. Falling gasoline prices had much to do with this. On a volume basis, retail sales rose 0.3%.</li>\n<li>The news has sent the loonie (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/FXC\" title=\"Invesco CurrencyShares Canadian Dollar Trust ETF\">FXC</a>) lower vs. the greenback, now <font color=\"red\">down 0.7% </font>on the session to $0.7613.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210549\" data-linked=\"Loonie lower on soft economic data\" data-tweet=\"$FXC - Loonie lower on soft economic data https://seekingalpha.com/news/3210549-loonie-lower-on-soft-economic-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3210549-loonie-lower-on-soft-economic-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210547\" data-ts=\"1474636494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210547-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> MIFI <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/BLRX' title='BioLineRx Ltd.'>BLRX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/IMPV' title='Imperva, Inc.'>IMPV</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/TWER-OLD' title='Towerstream Corporation'>TWER</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy Inc.'>ENPH</a> <font color='red'>-32%</font>. <a href='https://seekingalpha.com/symbol/IPCI' title='IntelliPharmaCeutics International Inc'>IPCI</a> <font color='red'>-9%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3210547\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$INSG $BLRX $TWTR - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3210547-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3210547-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210545\" data-ts=\"1474635967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210545-twitterplus-17-pre-market-m-speculation-recirculating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter +17% pre-market, M&amp;A speculation recirculating</a></h4><ul>\n<li>\n<a href=\"http://www.cnbc.com/2016/09/23/twitter-may-receive-formal-bid-shortly-suitors-said-to-include-salesforce-and-google.html\" target=\"_blank\">CNBC reports</a> Salesforce (NYSE:<a href=\"https://seekingalpha.com/symbol/CRM\" title=\"Salesforce.com, Inc.\">CRM</a>), Alphabet (<a href=\"https://seekingalpha.com/symbol/GOOG/focus\" target=\"_blank\">GOOG</a>, <a href=\"https://seekingalpha.com/symbol/GOOGL/focus\" target=\"_blank\">GOOGL</a>) and others have expressed potential interest.</li>\n<li>The move upward follows an <a href=\"https://seekingalpha.com/news/3210456-twitter-downgraded-underperform-rbc-capital-minus-2_5-percent-hours\" target=\"_blank\">RBC Capital Markets' downgrade</a> to Underperform that sent Twitter (NYSE:<a href=\"https://seekingalpha.com/symbol/TWTR\" title=\"Twitter, Inc.\">TWTR</a>) shares lower in yesterday's extended trading session.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210545\" data-linked=\"Twitter +17% pre-market, M&amp;A speculation recirculating\" data-tweet=\"$CRM $CRM $TWTR - Twitter +17% pre-market, M&amp;A speculation recirculating https://seekingalpha.com/news/3210545-twitterplus-17-pre-market-m-speculation-recirculating?source=tweet\" data-url=\"https://seekingalpha.com/news/3210545-twitterplus-17-pre-market-m-speculation-recirculating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>100&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210540\" data-ts=\"1474635203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CATB\" target=\"_blank\">CATB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210540-catabasis-pharmaceuticals-announces-10m-equity-offering-shares-down-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catabasis Pharmaceuticals announces $10M equity offering; shares down 14%</a></h4><ul> <li>Catabasis       Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/CATB\" title=\"Catabasis Pharmaceuticals\">CATB</a>) announces the pricing of an underwritten offering of       2.5M shares of its common stock at a price of $4.00 per share yielding gross proceeds of $10M.</li>\n<li>Net proceeds will fund ongoing and planned clinical trials of       <a href=\"http://www.catabasis.com/clinical-trials-cat-1004-movedmd.php\" target=\"_blank\">edasalonexent</a> (CAT-1004), working capital and general corporate purposes.</li>     <li>Closing date is September 28.</li>\n<li>Shares down <font color=\"red\">14%</font> premarket.</li>               </ul><div class=\"tiny-share-widget\" data-id=\"3210540\" data-linked=\"Catabasis Pharmaceuticals announces $10M equity offering; shares down 14%\" data-tweet=\"$CATB - Catabasis Pharmaceuticals announces $10M equity offering; shares down 14% https://seekingalpha.com/news/3210540-catabasis-pharmaceuticals-announces-10m-equity-offering-shares-down-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3210540-catabasis-pharmaceuticals-announces-10m-equity-offering-shares-down-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210538\" data-ts=\"1474634691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEEL\" target=\"_blank\">SEEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210538-apricus-bio-inks-direct-stock-offering-0_35-shares-down-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apricus Bio inks direct stock offering at $0.35; shares down 10% premarket</a></h4><ul>\n<li>Apricus Biosciences (APRI) eases <font color=\"red\">10%</font> premarket on increased volume in response to its announcement of a direct equity offering to institutional investors generating gross proceeds of $4.6M.</li>\n<li>The company will issue ~13.1M shares of common stock at $0.35. For each share bought, investors will receive one five-year warrant to purchase 3/4 of a share of stock at $0.45. Net proceeds will fund working capital and general corporate purposes.</li>\n<li>Yesterday's close was $0.3977.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210538\" data-linked=\"Apricus Bio inks direct stock offering at $0.35; shares down 10% premarket\" data-tweet=\"$SEEL - Apricus Bio inks direct stock offering at $0.35; shares down 10% premarket https://seekingalpha.com/news/3210538-apricus-bio-inks-direct-stock-offering-0_35-shares-down-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3210538-apricus-bio-inks-direct-stock-offering-0_35-shares-down-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210533\" data-ts=\"1474634156\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENDP\" target=\"_blank\">ENDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210533-paul-campanelli-named-president-and-ceo-of-endo-international\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Paul Campanelli named President and CEO of Endo International</a></h4><ul>\n<li>Endo International plc (<a href=\"https://seekingalpha.com/symbol/ENDP\" title=\"Endo International plc\">ENDP</a>) announces that its Board of Directors has named Paul V. Campanelli President and Chief Executive Officer, effective immediately. Mr. Campanelli currently serves as President of Endo's Generic and OTC drugs business, Par Pharmaceutical, which accounts for ~60% of Endo's total revenues through the first half of 2016.</li> <li>Campanelli joined Endo in 2015 following Endo's acquisition of Par, where he had served as CEO since 2012.</li>  <li>Shares up <font color=\"green\">7%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210533\" data-linked=\"Paul Campanelli named President and CEO of Endo International\" data-tweet=\"$ENDP - Paul Campanelli named President and CEO of Endo International https://seekingalpha.com/news/3210533-paul-campanelli-named-president-and-ceo-of-endo-international?source=tweet\" data-url=\"https://seekingalpha.com/news/3210533-paul-campanelli-named-president-and-ceo-of-endo-international\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210530\" data-ts=\"1474633764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRU\" target=\"_blank\">PRU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210530-prudential-higher-goldman-makes-conviction-pick\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prudential higher as Goldman makes it a Conviction pick</a></h4><ul>\n<li>Analysts Michael Kovac and Rosalie Frazier <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/09/8489328/goldman-upgrades-prudential-to-buy-adds-to-conviction-li\" target=\"_blank\">cite four key factors</a>:</li>\n<li>Upward revision in EPS estimates after revising downward at this time last year.</li>\n<li>Reduced overhead costs, and boosted capital returns - $1B repurchase program and 20% dividend hike.</li>\n<li>A differentiated franchise - the two note <a href=\"https://seekingalpha.com/symbol/PRU\" title=\"Prudential Financial, Inc.\">PRU</a>'s high-quality asset management, and the Japan operation contributing 45% of net income.</li>\n<li>Higher interest rates should boost the stock's multiple. Prudential, they say, is among the most liquid insurers and trades at just half the S&amp;P's multiple.</li>\n<li>They add PRU to the Conviction List with $93 price target.</li>\n<li>Shares<font color=\"green\"> +1.7%</font> to $81.50 premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210530\" data-linked=\"Prudential higher as Goldman makes it a Conviction pick\" data-tweet=\"$PRU - Prudential higher as Goldman makes it a Conviction pick https://seekingalpha.com/news/3210530-prudential-higher-goldman-makes-conviction-pick?source=tweet\" data-url=\"https://seekingalpha.com/news/3210530-prudential-higher-goldman-makes-conviction-pick\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210526\" data-ts=\"1474633152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLRX\" target=\"_blank\">BLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210526-biolinerx-secures-license-for-novel-treatment-for-liver-failure-conditions-shares-up-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioLineRx secures license for novel treatment for liver failure conditions; shares up 18% premarket</a></h4><ul>\n<li>Thinly traded nano cap BioLineRx (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BLRX\" title=\"BioLineRx Ltd.\">BLRX</a>) is up <font color=\"green\">18%</font> premarket on increased volume in response to its announcement that it has signed an exclusive, worldwide agreement with <a href=\"http://in.bgu.ac.il/en/bgn/Pages/default.aspx\" target=\"_blank\">BGN Technologies</a> and <a href=\"http://www.hadasit.co.il/\" target=\"_blank\">Hadasit</a> for the in-licensing of a novel treatment for various liver failure conditions such as <a href=\"http://www.webmd.com/digestive-disorders/cirrhosis-liver\" target=\"_blank\">end-stage liver disease</a> (ESLD) and for conditions potentially leading to liver failure such as <a href=\"http://www.webmd.com/digestive-disorders/tc/nonalcoholic-steatohepatitis-nash-overview#1\" target=\"_blank\">non-alcoholic steatohepatitis</a> (NASH). This novel treatment, to be named BL-1220, is the second project in-licensed under the framework of the Company's strategic collaboration with Novartis Pharma AG for the screening and development of novel drug candidates.</li> <li>BL-1220 is an orally administered, novel composition of sodium alginate. Pre-clinical results obtained in animal models of liver impairment suggest that BL-1220 has strong hepato-protective effects. Collectively, the data demonstrate that BL-1220 is able to restore liver function. This technology could be directed toward rapid regeneration of normal liver in both acute and chronic conditions of liver injury.</li>  <li>In December 2014, BioLineRx and Novartis Pharma AG entered into a multi-year strategic collaboration to facilitate development and commercialization of Israeli-sourced drug candidates. As part of the agreement, Novartis made an equity investment in BioLineRx of $10M.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3210526\" data-linked=\"BioLineRx secures license for novel treatment for liver failure conditions; shares up 18% premarket\" data-tweet=\"$BLRX - BioLineRx secures license for novel treatment for liver failure conditions; shares up 18% premarket https://seekingalpha.com/news/3210526-biolinerx-secures-license-for-novel-treatment-for-liver-failure-conditions-shares-up-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3210526-biolinerx-secures-license-for-novel-treatment-for-liver-failure-conditions-shares-up-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210523\" data-ts=\"1474631737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLCM\" target=\"_blank\">BLCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210523-preliminary-results-in-ongoing-phase-1-2-study-shows-pediatric-patients-immune-deficiencies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Preliminary results in ongoing Phase 1/2 study shows pediatric patients with immune deficiencies treated with Bellicum Pharma&#39;s lead product candidate have remained disease-free for 13 months</a></h4><ul>\n<li>\n<a href=\"https://www.sec.gov/Archives/edgar/data/1358403/000135840316000265/a8-kqtr3x2016other.htm\" target=\"_blank\">Interim data </a>from 18 subjects in a Phase 1/2 clinical trial assessing Bellicum Pharmaceuticals' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BLCM\" title=\"Bellicum Pharmaceuticals\">BLCM</a>) lead product candidate BPX-501 in pediatric patients with primary immune deficiencies show all continue to be disease-free at a median of 13 months of follow-up with no treatment-related mortality after a T-depleted haploidentical hematopoietic stem cell transplant (HSCT) and infusion of BPX-501. The results were presented at the 2016 Biennial Meeting of the European Society for Immunodeficiencies in Barcelona.</li>\n<li>\n<a href=\"http://www.bellicum.com/product-candidates/bpx-501/\" target=\"_blank\">BPX-501</a> is an adjunct T cell therapy administered after an HSCT, using genetically modified donor T cells incorporating the <a href=\"http://www.bellicum.com/technology/caspacide/\" target=\"_blank\">CaspaCIDe</a> safety switch (designed to eliminate cells in the event of graft-versus-host disease).</li>\n<li>Read now <a href=\"https://seekingalpha.com/article/3979637-bellicum-pharmaceuticals-switch\" target=\"_blank\">Bellicum Pharmaceuticals - Switch On To This</a>\n</li>\n<li>\n<strong>Update</strong>: Shares are up <font color=\"green\">6%</font> premarket on light volume.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210523\" data-linked=\"Preliminary results in ongoing Phase 1/2 study shows pediatric patients with immune deficiencies treated with Bellicum Pharma&#39;s lead product candidate have remained disease-free for 13 months\" data-tweet=\"$BLCM - Preliminary results in ongoing Phase 1/2 study shows pediatric patients with immune deficiencies treated with Bellicum Pharma&#39;s lead product candidate have remained disease-free for 13 months https://seekingalpha.com/news/3210523-preliminary-results-in-ongoing-phase-1-2-study-shows-pediatric-patients-immune-deficiencies?source=tweet\" data-url=\"https://seekingalpha.com/news/3210523-preliminary-results-in-ongoing-phase-1-2-study-shows-pediatric-patients-immune-deficiencies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3210515\" data-ts=\"1474629572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FINL\" target=\"_blank\">FINL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3210515-on-finish-lines-fq2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Finish Line&#39;s FQ2</a></h4><ul>\n<li>Finish Line (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FINL\" title=\"The Finish Line, Inc.\">FINL</a>) reports comparable-store sales rose 5.1% in FQ2.</li>\n<li>Gross margin rate decreased 170 bps to 31.3%.</li>\n<li>SG&amp;A expense rate grew 10 bps to 24.4%.</li>\n<li>Adjusted operating margin rate slipped 170 bps to 6.9%.</li>\n<li>Merchandise inventory +1.6% Y/Y to $372.26M.</li>\n<li>Store count Y/Y: Finish Line -35  to 585; Branded shops -3 to 391; JackRabbit store -6 to 70.</li>\n<li>\n<b>FY2017 Guidance</b>: Comparable-store sales: +3% to +5%; Adjusted EPS: $1.50 to $1.56.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3210515\" data-linked=\"More on Finish Line&#39;s FQ2\" data-tweet=\"$FINL - More on Finish Line&#39;s FQ2 https://seekingalpha.com/news/3210515-on-finish-lines-fq2?source=tweet\" data-url=\"https://seekingalpha.com/news/3210515-on-finish-lines-fq2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":42,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}